Trial Profile
THE EFFECTS OF SITAXSENTAN ONCE DAILY DOSING ON PROTEINURIA, 24-HOUR BLOOD PRESSURE, AND ARTERIAL STIFFNESS IN SUBJECTS WITH CHRONIC KIDNEY DISEASE
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Jul 2023
Price :
$35
*
At a glance
- Drugs Sitaxentan (Primary) ; Nifedipine
- Indications Proteinuria; Renal failure
- Focus Therapeutic Use
- Acronyms FCRD01
- Sponsors Pfizer
- 12 May 2014 New trial record
- 19 May 2009